Killed but metabolically active vaccines.

Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy. Front Cell Infect Microbiol (2014) 0.96

Can biowarfare agents be defeated with light? Virulence (2013) 0.86

A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy. Mol Ther (2013) 0.79

Bacterial vectors for active immunotherapy reach clinical and industrial stages. Hum Vaccin Immunother (2012) 0.78

Scientific challenges and opportunities in developing novel vaccines for the emerging and developing markets: New Technologies in Emerging Markets, October 16th-18th 2012, World Vaccine Congress, Lyon. Hum Vaccin Immunother (2013) 0.75

Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania. Hum Vaccin Immunother (2014) 0.75

Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med (2004) 3.94

Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host Microbe (2010) 3.09

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood (2007) 2.93

Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci U S A (2008) 2.62

Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae. Mol Microbiol (2006) 2.31

A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin Cancer Res (2011) 1.78

Short-term genome evolution of Listeria monocytogenes in a non-controlled environment. BMC Genomics (2008) 1.74

Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity. Proc Natl Acad Sci U S A (2008) 1.63

Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity. Proc Natl Acad Sci U S A (2011) 1.37

Cytosolic entry controls CD8+-T-cell potency during bacterial infection. Infect Immun (2006) 1.29

Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. J Exp Med (2013) 1.25

Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes. Cancer Res (2006) 1.25

Dynamic imaging of the effector immune response to listeria infection in vivo. PLoS Pathog (2011) 1.16

Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains. Infect Immun (2008) 1.11

Invasive extravillous trophoblasts restrict intracellular growth and spread of Listeria monocytogenes. PLoS Pathog (2011) 1.09

Preliminary model of nitrogen loads from southern bluefin tuna aquaculture. Mar Pollut Bull (2007) 1.08

Pilus backbone contributes to group B Streptococcus paracellular translocation through epithelial cells. J Infect Dis (2008) 1.06

Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines. J Immunother (2009) 0.95

Clinical development of Listeria monocytogenes-based immunotherapies. Semin Oncol (2012) 0.95

Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease. J Immunol (2007) 0.94

Suppression of cell-mediated immunity following recognition of phagosome-confined bacteria. PLoS Pathog (2009) 0.93

Cutting edge: rapid boosting of cross-reactive memory CD8 T cells broadens the protective capacity of the Flumist vaccine. J Immunol (2013) 0.92

Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice. Infect Immun (2009) 0.91

KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity. J Clin Invest (2008) 0.88

Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases. Ann Surg Oncol (2011) 0.85

The impact of pre-existing memory on differentiation of newly recruited naive CD8 T cells. J Immunol (2011) 0.84

Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus. AIDS Res Hum Retroviruses (2015) 0.77

Operation of marine diesel engines on biogenic fuels: modification of emissions and resulting climate effects. Environ Sci Technol (2011) 0.75